Astrana Health, INC Form 4 insider transactions

Glenn Sobotka, Former Officer of Astrana Health, Inc., reported a transaction in 11,793 shares of common stock on August 7, 2026.

Director David Schmidt was granted 4,525 restricted shares of Astrana Health, Inc. common stock.

Director Matthew Mazdyasni was granted 4,525 restricted shares of Astrana Health, Inc. common stock.

Director Mitchell W. Kitayama was granted 4,991 restricted shares of Astrana Health common stock.

Astrana Health, Inc. director Linda Dong was granted 4,525 restricted shares of common stock vesting in June 2027.

Astrana Health Director Weili Dai acquired 4,525 restricted shares of common stock, vesting by June 2027, under the company's 2024 Equity Incentive Plan.

Chandan Basho, COO and CFO of Astrana Health, Inc., reported a transaction involving the surrender of shares to cover tax withholding obligations upon the vesting of restricted stock.

Chandan Basho, COO and CFO of Astrana Health, Inc., reported a transaction involving the surrender of shares to cover tax withholding obligations upon the vesting of restricted stock.

Astrana Health, Inc. director Thomas S. Lam was granted restricted stock units and restricted stock, with vesting schedules detailed.

Kenneth T. Sim, Executive Chairman of Astrana Health, Inc., reported the acquisition of 100,000 restricted stock units on April 6, 2026.

Astrana Health CEO Brandon Sim was granted restricted stock units and acquired additional shares, impacting his beneficial ownership.

Astrana Health's Chief Medical Officer, Dinesh M. Kumar, reported transactions involving common stock, including vesting of performance-based RSUs and tax withholding.

Chandan Basho, COO and CFO of Astrana Health, Inc., reported transactions involving common stock, including the surrender of shares for tax withholding and details on unvested restricted stock and units.

Astrana Health’s Chief Accounting Officer surrendered 662 shares at $24.27 to cover taxes on RSU vesting, retaining 14,039 shares including unvested awards with time- and performance-based conditions.

Astrana Health's CEO and President, Brandon Sim, acquired 21,334 shares of common stock through option exercise on February 2, 2026.

Astrana Health's Chief Medical Officer, Dinesh M. Kumar, disposed of 10,759 shares to cover tax obligations related to restricted stock vesting.

Astrana Health Director David Schmidt exercised 20,000 stock options and subsequently sold 4,269 shares for tax withholding, increasing his direct beneficial ownership to 31,494 common shares.

Astrana Health's Chief Medical Officer, Dinesh M. Kumar, disposed of 5,102 shares of common stock to cover tax withholding obligations related to vested restricted stock.

Astrana Health Director Thomas S. Lam exercised stock options and sold a portion of the resulting shares for tax purposes, as detailed in a recent SEC Form 4 filing.

Kenneth T. Sim, Executive Chairman of Astrana Health, Inc., exercised stock options to acquire 29,502 shares of common stock at $17.78 per share.

Astrana Health, Inc. Director Mitchell W. Kitayama acquired 12,000 shares of common stock through a pre-planned option exercise, increasing his direct beneficial ownership.

Astrana Health Director Matthew Mazdyasni exercised 20,000 stock options, increasing his direct common stock holdings.

Astrana Health Director Linda Marsh reported exercising stock options and subsequently selling shares for tax withholding purposes.

Chandan Basho, Astrana Health's COO and CFO, disposed of 1,979 common shares on October 2, 2025, to satisfy tax withholding obligations from vested restricted stock units.

Astrana Health Director Mitchell W. Kitayama exercised stock options and subsequently sold a portion of his common stock back to the issuer.

Astrana Health's COO and CFO, Chandan Basho, disposed of 1,694 shares of common stock to cover tax liabilities related to vested restricted stock units.

Astrana Health's Chief Medical Officer, Dinesh M. Kumar, disposed of 1,694 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Astrana Health Director David Schmidt exercised stock options and subsequently sold 20,000 shares back to the issuer.

Astrana Health Director John Chiang exercised 20,000 stock options and subsequently sold 12,284 shares for tax purposes, reducing his direct beneficial ownership.

Astrana Health's Chief Medical Officer, Dinesh M. Kumar, reported the surrender of 6,831 shares of common stock valued at $25.06 per share to cover tax withholding obligations related to restricted stock vesting, maintaining a beneficial ownership of 218,811 shares.